Trastuzumab in early curative breast cancer: A target trial emulation benchmarked against two randomized clinical trials

Journal:
PLOS Medicine
Published:
Affiliations:
3
Authors:
6
Institutions Authors Share
Karolinska Institute (KI), Sweden
3.500000
0.58
Charité - University Medicine Berlin, Germany
1.500000
0.25
Barcelona RTI Health Solutions, Spain
1.000000
0.17